Recursion Pharmaceuticals (RXRX) Cash & Current Investments (2020 - 2026)
Recursion Pharmaceuticals' Cash & Current Investments was $545.68 million in Q2 2026, up 3.9% from $525.11 million a year earlier but down 16.6% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Recursion Pharmaceuticals came in at $743.29 million, up 25.1% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $594.35 million in FY2024 (+51.8%), $391.57 million in FY2023 (-28.8%), $549.91 million in FY2022 (+6.5%) and $516.56 million in FY2021 (+97.1%).
- Quarterly Cash & Current Investments has moved between $296.33 million (Q1 2024) and $743.29 million (Q4 2025) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for nine straight quarters, with growth averaging 32.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2022 (growth of 176.1%); the worst was Q1 2024 (a decline of 37.4%).
- Per Business Quant data, RXRX's Cash & Current Investments in the three quarters before Q2 2026 was $654.47 million (Q1 2026), $743.29 million (Q4 2025) and $659.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Recursion Pharmaceuticals | 2.20 Bn | -402.71 Mn | -3.82 Mn | 545.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 545.68 Mn |
| Mar 31, 2026 | 654.47 Mn |
| Dec 31, 2025 | 743.29 Mn |
| Sep 30, 2025 | 659.84 Mn |
| Jun 30, 2025 | 525.11 Mn |
| Mar 31, 2025 | 500.45 Mn |
| Dec 31, 2024 | 594.35 Mn |
| Sep 30, 2024 | 427.65 Mn |
| Jun 30, 2024 | 474.34 Mn |
| Mar 31, 2024 | 296.33 Mn |
| Dec 31, 2023 | 391.57 Mn |
| Sep 30, 2023 | 387.32 Mn |
| Jun 30, 2023 | 405.87 Mn |
| Mar 31, 2023 | 473.15 Mn |
| Dec 31, 2022 | 549.91 Mn |
| Sep 30, 2022 | 454.65 Mn |
| Jun 30, 2022 | 515.44 Mn |
| Mar 31, 2022 | 591.11 Mn |
| Dec 31, 2021 | 516.56 Mn |
| Sep 30, 2021 | 578.91 Mn |
API Access
Recursion Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();